The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study
Autor: | Serra-Burriel, Miquel, Perényi, Gellért, Laube, Yannic, Mitchell, Aaron P., Vokinger, Kerstin N. |
---|---|
Zdroj: | In eClinicalMedicine July 2023 61 |
Databáze: | ScienceDirect |
Externí odkaz: |